VECTICANN
LIVE

Serial Number

79418894

Owner

113 BOTANICALS LIMITED

Attorney

Scott McCollister

Filing Date

Jan 6, 2025

Add to watchlist:

No watchlists yet
View on USPTO

VECTICANN Trademark

Serial Number: 79418894 • Registration: 8217386

VECTICANN is a trademark filed by 113 BOTANICALS LIMITED on January 6, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

113 BOTANICALS LIMITED (2 trademarks)

1 Royal Terrace

Entity Type: 99

Trademark Details

Filing Date

January 6, 2025

Registration Date

April 21, 2026

Published for Opposition

March 3, 2026

Goods & Services

Medicinal preparations for treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; transdermal patches for use in the treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; adhesive skin patches for medical purposes, namely, treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; medicated skin preparations, namely skin patches, for treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 21, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2026 PUBO
NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2026 NREP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 25, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2026 TROA
REFUSAL PROCESSED BY IB
Aug 23, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 6, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 6, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 17, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jun 16, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 16, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 16, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 13, 2025 REPR